Madsen K - Search Results

1

A new series of highly potent growth hormone-releasing peptides derived from ipamorelin.

Ankersen M, Johansen NL, Madsen K, Hansen BS, Raun K, Nielsen KK, Thogersen H, Hansen TK, Peschke B, Lau J, Lundt BF, Andersen PH. Ankersen M, et al. Among authors: madsen k. J Med Chem. 1998 Sep 10;41(19):3699-704. doi: 10.1021/jm9801962. J Med Chem. 1998. PMID: 9733495

2

Novel orally active growth hormone secretagogues.

Hansen TK, Ankersen M, Hansen BS, Raun K, Nielsen KK, Lau J, Peschke B, Lundt BF, Thøgersen H, Johansen NL, Madsen K, Andersen PH. Hansen TK, et al. Among authors: madsen k. J Med Chem. 1998 Sep 10;41(19):3705-14. doi: 10.1021/jm980197u. J Med Chem. 1998. PMID: 9733496

3

Ipamorelin, the first selective growth hormone secretagogue.

Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH. Raun K, et al. Among authors: madsen k. Eur J Endocrinol. 1998 Nov;139(5):552-61. doi: 10.1530/eje.0.1390552. Eur J Endocrinol. 1998. PMID: 9849822

4

Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration.

Knudsen LB, Nielsen PF, Huusfeldt PO, Johansen NL, Madsen K, Pedersen FZ, Thøgersen H, Wilken M, Agersø H. Knudsen LB, et al. Among authors: madsen k. J Med Chem. 2000 May 4;43(9):1664-9. doi: 10.1021/jm9909645. J Med Chem. 2000. PMID: 10794683

5

Important role of C-terminal peptide bonds for endothelin receptor binding and activity.

Olsen UB, Weis JU, Suzdak P, Lundt BF, Madsen K, Thøgersen H, Johansen NL. Olsen UB, et al. Among authors: madsen k. Pharmacol Toxicol. 1993 Jul;73(1):60-2. doi: 10.1111/j.1600-0773.1993.tb01960.x. Pharmacol Toxicol. 1993. PMID: 8234195 No abstract available.

6

Ketomethylene and (cyanomethylene)amino pseudopeptide analogues of the C-terminal hexapeptide of neurotensin.

González-Muñiz R, García-López MT, Gómez-Monterrey I, Herranz R, Jimeno ML, Suárez-Gea ML, Johansen NL, Madsen K, Thøgersen H, Suzdak P. González-Muñiz R, et al. Among authors: madsen k. J Med Chem. 1995 Mar 17;38(6):1015-21. doi: 10.1021/jm00006a021. J Med Chem. 1995. PMID: 7699693

7

[3H]ac-RYYRWK-NH2, a novel specific radioligand for the nociceptin/orphanin FQ receptor.

Thomsen C, Valsborg JS, Platou J, Martin J, Foged C, Johansen NL, Olsen UB, Madsen K. Thomsen C, et al. Among authors: madsen k. Naunyn Schmiedebergs Arch Pharmacol. 2000 Dec;362(6):538-45. doi: 10.1007/s002100000307. Naunyn Schmiedebergs Arch Pharmacol. 2000. PMID: 11138846

8

Superiority of sandwich ELISA over competitive RIA for the estimation of ANP-270, an analogue of human atrial natriuretic factor.

Ingwersen SH, Jørgensen PN, Eiskjaer H, Johansen NL, Madsen K, Faarup P. Ingwersen SH, et al. Among authors: madsen k. J Immunol Methods. 1992 May 18;149(2):237-46. doi: 10.1016/0022-1759(92)90255-r. J Immunol Methods. 1992. PMID: 1534341

9

Implications of replacing peptide bonds in the COOH-terminal B chain domain of insulin by the psi (CH2-NH) linker.

Nakagawa SH, Johansen NL, Madsen K, Schwartz TW, Tager HS. Nakagawa SH, et al. Among authors: madsen k. Int J Pept Protein Res. 1993 Dec;42(6):578-84. doi: 10.1111/j.1399-3011.1993.tb00367.x. Int J Pept Protein Res. 1993. PMID: 8307689

10

Selective and potent inhibition of human CYP2C19 activity by a conformationally targeted antipeptide antibody.

Schulz-Utermoehl T, Mountfield RJ, Madsen K, Jørgensen PN, Hansen KT. Schulz-Utermoehl T, et al. Among authors: madsen k. Drug Metab Dispos. 2000 Jul;28(7):715-7. Drug Metab Dispos. 2000. PMID: 10859141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,210 results

Search Page

Filters